Tested Applications
| Positive WB detected in | Caco-2 cells, RAW 264.7 cells |
| Positive IHC detected in | mouse liver tissue, human liver tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive FC (Intra) detected in | LPS treated RAW 264.7 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:250-1:1000 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
22226-1-AP targets iNOS in WB, IHC, IF, FC (Intra), CoIP, ELISA, Cell treatment, qPCR, Western Blot applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse, rat, rabbit, chicken |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag17567 Product name: Recombinant human NOS2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-190 aa of BC130283 Sequence: MACPWKFLFKTKFHQYAMNGEKDINNNVEKAPCATSSPVTQDDLQYHNLSKQQNESPQPLVETGKKSPESLVKLDATPLSSPRHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFAT Predict reactive species |
| Full Name | nitric oxide synthase 2, inducible |
| Calculated Molecular Weight | 1153 aa, 131 kDa |
| Observed Molecular Weight | 110-130 kDa, 65-70 kDa |
| GenBank Accession Number | BC130283 |
| Gene Symbol | iNOS |
| Gene ID (NCBI) | 4843 |
| RRID | AB_2879038 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P35228 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
NOS2, also named as iNOS and NOS2A, produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. NO is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission, antimicrobial and antitumoral activities. NOS2 is a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. iNOS has a very short half-life due to rapid degradation by calpain. iNOS monomer is a direct substrate of calpain I and can be cleaved by calpain I at the canonical CaM-binding site(503-532aa) of iNOS, and then a ~70kD band can be detected by western (PMID:11786228).
Protocols
| Product Specific Protocols | |
|---|---|
| FC protocol for iNOS antibody 22226-1-AP | Download protocol |
| IHC protocol for iNOS antibody 22226-1-AP | Download protocol |
| WB protocol for iNOS antibody 22226-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The iNOS Polyclonal antibody (Cat# 22226-1-AP) has 459 total citations. Publications appear in high-impact journals including Nature Communications, Advanced Materials, Bioactive Materials, ACS Nano, Theranostics, Biomaterials, Advanced Science, Journal of Nanobiotechnology, Redox Biology, Journal of Neuroinflammation, Phytomedicine, and Brain, Behavior, and Immunity. Key research fields encompass neuroinflammation, macrophage polarization, diabetic wound healing, bone regeneration, spinal cord injury, atherosclerosis, rheumatoid arthritis, osteoarthritis, liver fibrosis, cancer immunology, sepsis, myocardial infarction, and neurodegenerative diseases.
| Species | Application | Title |
|---|---|---|
Signal Transduct Target Ther Nature-inspired confined cascade enzyme nanoreactors for targeted atherosclerosis therapy. | ||
Exploration (Beijing) Targeting eEF1A1 With Baicalein to Block eEF1A1/Prdx4 Interaction for Treating Sepsis-Mediated Lung Injury | ||
Adv Mater Photothermal and Photocatalytic Glycol Chitosan and Polydopamine-Grafted Oxygen Vacancy Bismuth Oxyiodide (BiO1-x I) Nanoparticles for the Diagnosis and Targeted Therapy of Diabetic Wounds | ||
Bioact Mater Immunomodulatory effects of biodegradable Mg-Cu-Zn alloy in esophageal cancer. | ||
Bioact Mater A tantalum-containing zirconium-based metallic glass with superior endosseous implant relevant properties |













